168 related articles for article (PubMed ID: 25600456)
1. [MHC class I antigens, CD4 and CD8 expressions in polymyositis and dermatomyositis].
Graça CR; Kouyoumdjian JA
Rev Bras Reumatol; 2015; 55(3):203-8. PubMed ID: 25600456
[TBL] [Abstract][Full Text] [Related]
2. CD8/MHC-I complex is specific but not sensitive for the diagnosis of polymyositis.
Dai TJ; Li W; Zhao QW; Zhao YY; Liu SP; Yan CZ
J Int Med Res; 2010; 38(3):1049-59. PubMed ID: 20819442
[TBL] [Abstract][Full Text] [Related]
3. Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies.
Englund P; Lindroos E; Nennesmo I; Klareskog L; Lundberg IE
Am J Pathol; 2001 Oct; 159(4):1263-73. PubMed ID: 11583954
[TBL] [Abstract][Full Text] [Related]
4. MHC class I and II expression in juvenile dermatomyositis skeletal muscle.
Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Sachetti S; Lotufo S; Matsumura N; Marie SK
Clin Exp Rheumatol; 2009; 27(3):519-26. PubMed ID: 19604449
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue.
Englund P; Nennesmo I; Klareskog L; Lundberg IE
Arthritis Rheum; 2002 Apr; 46(4):1044-55. PubMed ID: 11953983
[TBL] [Abstract][Full Text] [Related]
6. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production.
Sugiura T; Kawaguchi Y; Harigai M; Takagi K; Ohta S; Fukasawa C; Hara M; Kamatani N
J Immunol; 2000 Jun; 164(12):6593-600. PubMed ID: 10843719
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic inflammatory myopathies. Immunohistochemical analysis of the major histocompatibility complex antigen expression, inflammatory infiltrate phenotype and activation cell markers.
Pedrol E; Grau JM; Casademont J; Cid MC; Masanés F; Fernandez-Sola J; Urbano-Márquez A
Clin Neuropathol; 1995; 14(3):179-84. PubMed ID: 7671462
[TBL] [Abstract][Full Text] [Related]
8. [The immunoreactivity studies of the idiopathic inflammatory myopathy over the past three years in our laboratory].
Hiruma S; Ohtsuka K; Satou T; Furuta T; Kimura M; Hashimoto S
Rinsho Byori; 1998 Feb; 46(2):168-75. PubMed ID: 9528342
[TBL] [Abstract][Full Text] [Related]
9. Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies: CD4+ T cells cause muscle cell injury directly in polymyositis.
Sugiura T; Murakawa Y; Nagai A; Kondo M; Kobayashi S
Arthritis Rheum; 1999 Feb; 42(2):291-8. PubMed ID: 10025923
[TBL] [Abstract][Full Text] [Related]
10. Differential immunohistological features of inflammatory myopathies and dysferlinopathy.
Choi JH; Park YE; Kim SI; Kim JI; Lee CH; Park KH; Kim DS
J Korean Med Sci; 2009 Dec; 24(6):1015-23. PubMed ID: 19949654
[TBL] [Abstract][Full Text] [Related]
11. Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis.
Suárez-Calvet X; Gallardo E; Nogales-Gadea G; Querol L; Navas M; Díaz-Manera J; Rojas-Garcia R; Illa I
J Pathol; 2014 Jul; 233(3):258-68. PubMed ID: 24604766
[TBL] [Abstract][Full Text] [Related]
12. T-cell receptor-mediated characteristic signaling pathway of peripheral blood T cells in dermatomyositis and polymyositis.
Shimojima Y; Matsuda M; Ishii W; Kishida D; Sekijima Y
Autoimmunity; 2017 Dec; 50(8):481-490. PubMed ID: 29172719
[TBL] [Abstract][Full Text] [Related]
13. cDNA microarrays reveal distinct gene expression clusters in idiopathic inflammatory myopathies.
Zhou X; Dimachkie MM; Xiong M; Tan FK; Arnett FC
Med Sci Monit; 2004 Jul; 10(7):BR191-7. PubMed ID: 15232492
[TBL] [Abstract][Full Text] [Related]
14. Major histocompatibility complex class I expression can be used as a diagnostic tool to differentiate idiopathic inflammatory myopathies from dystrophies.
Sundaram C; Uppin MS; Meena AK
Neurol India; 2008; 56(3):363-7. PubMed ID: 18974565
[TBL] [Abstract][Full Text] [Related]
15. T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients.
Houtman M; Ekholm L; Hesselberg E; Chemin K; Malmström V; Reed AM; Lundberg IE; Padyukov L
Arthritis Res Ther; 2018 Aug; 20(1):188. PubMed ID: 30157932
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex and inflammatory cell subtype expression in inflammatory myopathies and muscular dystrophies.
Nagappa M; Nalini A; Narayanappa G
Neurol India; 2013; 61(6):614-21. PubMed ID: 24441329
[TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy.
Das L; Blumbergs PC; Manavis J; Limaye VS
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):539-42. PubMed ID: 23343957
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis.
Nyberg P; Wikman AL; Nennesmo I; Lundberg I
J Rheumatol; 2000 Apr; 27(4):940-8. PubMed ID: 10782820
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
Choi YC; Dalakas MC
Neurology; 2000 Jan; 54(1):65-71. PubMed ID: 10636127
[TBL] [Abstract][Full Text] [Related]
20. Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells.
Nagaraju K; Raben N; Villalba ML; Danning C; Loeffler LA; Lee E; Tresser N; Abati A; Fetsch P; Plotz PH
Clin Immunol; 1999 Aug; 92(2):161-9. PubMed ID: 10444360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
